187 related articles for article (PubMed ID: 3115194)
1. Collagen biosynthesis and isomorphism in a case of Ehlers-Danlos syndrome type VI.
Chamson A; Berbis P; Fabre JF; Privat Y; Frey J
Arch Dermatol Res; 1987; 279(5):303-7. PubMed ID: 3115194
[TBL] [Abstract][Full Text] [Related]
2. A comparison of lysyl hydroxylation in various types of collagen from type VI Ehlers-Danlos syndrome fibroblasts.
Tajima S; Murad S; Pinnell SR
Coll Relat Res; 1983 Nov; 3(6):511-5. PubMed ID: 6421539
[TBL] [Abstract][Full Text] [Related]
3. Abnormal formation of collagen cross-links in skin fibroblasts cultured from patients with Ehlers-Danlos syndrome type VI.
Pasquali M; Still MJ; Vales T; Rosen RI; Evinger JD; Dembure PP; Longo N; Elsas LJ
Proc Assoc Am Physicians; 1997 Jan; 109(1):33-41. PubMed ID: 9010914
[TBL] [Abstract][Full Text] [Related]
4. Collagen synthesis by cultured skin fibroblasts from siblings with hydroxylysine-deficient collagen.
Quinn RS; Krane SM
Biochim Biophys Acta; 1979 Jul; 585(4):589-98. PubMed ID: 465542
[TBL] [Abstract][Full Text] [Related]
5. Ehlers-Danlos syndrome type VI: collagen type specificity of defective lysyl hydroxylation in various tissues.
Ihme A; Krieg T; Nerlich A; Feldmann U; Rauterberg J; Glanville RW; Edel G; Müller PK
J Invest Dermatol; 1984 Sep; 83(3):161-5. PubMed ID: 6432919
[TBL] [Abstract][Full Text] [Related]
6. Ascorbate regulation of collagen biosynthesis in Ehlers-Danlos syndrome, type VI.
Dembure PP; Janko AR; Priest JH; Elsas LJ
Metabolism; 1987 Jul; 36(7):687-91. PubMed ID: 3110540
[TBL] [Abstract][Full Text] [Related]
7. Biochemical characteristics of Ehlers-Danlos syndrome type VI in a family with one affected infant.
Krieg T; Feldmann U; Kessler W; Müller PK
Hum Genet; 1979 Jan; 46(1):41-9. PubMed ID: 429005
[TBL] [Abstract][Full Text] [Related]
8. Ehlers-Danlos syndrome. A variant characterized by the deficiency of pro alpha 2 chain of type I procollagen.
Sasaki T; Arai K; Ono M; Yamaguchi T; Furuta S; Nagai Y
Arch Dermatol; 1987 Jan; 123(1):76-9. PubMed ID: 3800425
[TBL] [Abstract][Full Text] [Related]
9. Biochemical characterization of variants of the Ehlers-Danlos syndrome type VI.
Ihme A; Risteli L; Krieg T; Risteli J; Feldmann U; Kruse K; Müller PK
Eur J Clin Invest; 1983 Aug; 13(4):357-62. PubMed ID: 6413223
[TBL] [Abstract][Full Text] [Related]
10. Adenoviral gene transfer restores lysyl hydroxylase activity in type VI Ehlers-Danlos syndrome.
Rauma T; Kumpumäki S; Anderson R; Davidson BL; Ruotsalainen H; Myllylä R; Hautala T
J Invest Dermatol; 2001 Apr; 116(4):602-5. PubMed ID: 11286629
[TBL] [Abstract][Full Text] [Related]
11. Preferential hydroxylation of type IV collagen by lysyl hydroxylase from Ehlers-Danlos syndrome type VI fibroblasts.
Risteli L; Risteli J; Ihme A; Krieg T; Müller PK
Biochem Biophys Res Commun; 1980 Oct; 96(4):1778-84. PubMed ID: 6778480
[No Abstract] [Full Text] [Related]
12. Lysine hydroxylation of collagen in a fibroblast cell culture system.
Uzawa K; Yeowell HN; Yamamoto K; Mochida Y; Tanzawa H; Yamauchi M
Biochem Biophys Res Commun; 2003 Jun; 305(3):484-7. PubMed ID: 12763018
[TBL] [Abstract][Full Text] [Related]
13. Decreased expression of lysyl hydroxylase 2 (LH2) in skin fibroblasts from three Ehlers-Danlos patients does not result from mutations in either the coding or proximal promoter region of the LH2 gene.
Walker LC; Teebi AS; Marini JC; De Paepe A; Malfait F; Atsawasuwan P; Yamauchi M; Yeowell HN
Mol Genet Metab; 2004 Dec; 83(4):312-21. PubMed ID: 15589118
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneous basis of the type VIB form of Ehlers-Danlos syndrome (EDS VIB) that is unrelated to decreased collagen lysyl hydroxylation.
Walker LC; Overstreet MA; Willing MC; Marini JC; Cabral WA; Pals G; Bristow J; Atsawasuwan P; Yamauchi M; Yeowell HN
Am J Med Genet A; 2004 Dec; 131(2):155-62. PubMed ID: 15523625
[TBL] [Abstract][Full Text] [Related]
15. Low levels of serum type III procollagen aminoterminal propeptide confirmed type III collagen deficiency in patients without typical clinical symptoms of Ehlers-Danlos type IV.
Dyne KM; Zanaboni G; Annoni G; De Agostini MP; Cetta G
Eur J Clin Invest; 1989 Aug; 19(4):362-6. PubMed ID: 2506053
[TBL] [Abstract][Full Text] [Related]
16. Biochemical and immunological studies of fibroblasts derived from a patient with Ehlers-Danlos syndrome type IV. Demonstrate reduced type III collagen synthesis.
Aumailley M; Krieg T; Dessau W; Müller PK; Timpl R; Bricaud H
Arch Dermatol Res; 1980; 269(2):169-77. PubMed ID: 7458408
[TBL] [Abstract][Full Text] [Related]
17. Low production of procollagen III by skin fibroblasts from patients with Ehlers-Danlos syndrome type IV is not caused by decreased levels of procollagen III mRNA.
Aumailley M; Pöschl E; Martin GR; Yamada Y; Müller PK
Eur J Clin Invest; 1988 Apr; 18(2):207-12. PubMed ID: 3133227
[TBL] [Abstract][Full Text] [Related]
18. Patients with Ehlers-Danlos syndrome type IV lack type III collagen.
Pope FM; Martin GR; Lichtenstein JR; Penttinen R; Gerson B; Rowe DW; McKusick VA
Proc Natl Acad Sci U S A; 1975 Apr; 72(4):1314-6. PubMed ID: 1055406
[TBL] [Abstract][Full Text] [Related]
19. Inheritance of Ehlers-Danlos type IV syndrome.
Pope FM; Martin GR; McKusick VA
J Med Genet; 1977 Jun; 14(3):200-4. PubMed ID: 881711
[TBL] [Abstract][Full Text] [Related]
20. Alterations in copper and collagen metabolism in the Menkes syndrome and a new subtype of the Ehlers-Danlos syndrome.
Peltonen L; Kuivaniemi H; Palotie A; Horn N; Kaitila I; Kivirikko KI
Biochemistry; 1983 Dec; 22(26):6156-63. PubMed ID: 6140952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
